Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather J Dalton

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Cancer|January 24, 2017
Racial disparities in cervical cancer: Worse than we thoughtHeather J Dalton, John H Farley
Gynecologic Oncology Research and Practice|May 28, 2016
Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathwaysCassandra D Foss, Heather J Dalton, Bradley J Monk, et al.
Gynecologic Oncology|February 1, 2017
Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experienceHeather J Dalton, Nicole D Fleming, Charlotte C Sun, et al.
Gynecologic Oncology|November 8, 2011
An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancerHeather J Dalton, Xinhua Yu, Lilian Hu, et al.
Cancer Research|February 22, 2014
Monocyte subpopulations in angiogenesisHeather J Dalton, Guillermo N Armaiz-Pena, Vianey Gonzalez-Villasana, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
In vitro chemoresponse in metachronous pairs of gyneclologic cancersHeather J Dalton, James Fiorica, Candace K McClure, et al.
Gynecologic Oncology|December 4, 2012
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerCristina Ivan, Wei Hu, Justin Bottsford-Miller, et al.
Molecular Cancer Therapeutics|April 3, 2015
PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine CancerDuangmani Thanapprapasr, Rebecca A Previs, Wei Hu, et al.
Anticancer Research|December 16, 2014
In vitro chemoresponse in metachronous pairs of ovarian cancersHeather J Dalton, James V Fiorica, Robert P Edwards, et al.
Molecular Cancer Therapeutics|October 31, 2015
Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian CancerRebecca A Previs, Guillermo N Armaiz-Pena, Yvonne G Lin, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Cancer|January 24, 2017
Racial disparities in cervical cancer: Worse than we thoughtHeather J Dalton, John H Farley
Gynecologic Oncology Research and Practice|May 28, 2016
Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathwaysCassandra D Foss, Heather J Dalton, Bradley J Monk, et al.
Gynecologic Oncology|February 1, 2017
Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experienceHeather J Dalton, Nicole D Fleming, Charlotte C Sun, et al.
Gynecologic Oncology|November 8, 2011
An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancerHeather J Dalton, Xinhua Yu, Lilian Hu, et al.
Cancer Research|February 22, 2014
Monocyte subpopulations in angiogenesisHeather J Dalton, Guillermo N Armaiz-Pena, Vianey Gonzalez-Villasana, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
In vitro chemoresponse in metachronous pairs of gyneclologic cancersHeather J Dalton, James Fiorica, Candace K McClure, et al.
Gynecologic Oncology|December 4, 2012
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerCristina Ivan, Wei Hu, Justin Bottsford-Miller, et al.
Molecular Cancer Therapeutics|April 3, 2015
PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine CancerDuangmani Thanapprapasr, Rebecca A Previs, Wei Hu, et al.
Anticancer Research|December 16, 2014
In vitro chemoresponse in metachronous pairs of ovarian cancersHeather J Dalton, James V Fiorica, Robert P Edwards, et al.
Molecular Cancer Therapeutics|October 31, 2015
Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian CancerRebecca A Previs, Guillermo N Armaiz-Pena, Yvonne G Lin, et al.
Pageof 4